For Daniel Diaz, it’s not just a job: He’s motivated by the belief that one day we’ll have a better understanding of all diseases
How MicroGenDX is moving toward faster, better detection of uncommon and rare pathogens
The company was recently recognized for its inclusive practices and supportive environment
Illumina is executing on our strategy to simplify workflows—and that has the power to unlock greater impact for our customers
National Animal Health Laboratory Network member labs are adopting Illumina DNA library prep to support disease surveillance
| Date | Publication | Title |
|---|---|---|
| 23 Jun 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| 17 Jun 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| 13 Jun 2025 | GEN | Silver Anniversary of the Human Genome Project |
| 13 Jun 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| 12 Jun 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.